Encephalitis in dogs is inflammation of the brain that can stem from infection, an overactive immune system, or sometimes both. It is one of the more serious neurological conditions veterinarians encounter, and in many cases the exact cause is never pinpointed. The disease tends to be split into two broad camps: infectious encephalitis, caused by viruses, parasites, or bacteria that directly invade the brain, and immune-mediated encephalitis, where the dog’s own immune system attacks brain tissue for reasons that remain partly mysterious. Treatment, prognosis, and urgency all depend on which camp a dog falls into, so understanding the distinction matters from the moment symptoms appear.
The Two Major Categories
When a dog develops encephalitis, the first question a veterinary neurologist tries to answer is whether an infectious organism is responsible or whether the immune system has gone rogue. Infectious encephalitis has a clear culprit: a pathogen that has reached the central nervous system and is actively damaging neurons. The most common infectious agents include canine distemper virus, tick-borne encephalitis virus, and certain parasites like Toxoplasma gondii and Neospora caninum.1Europe PMC. Conventional and molecular diagnostic testing for the acute neurologic patient These organisms can be identified through PCR testing, antibody titers, or sometimes direct visualization on tissue samples.
Immune-mediated encephalitis is a different beast. In these cases, no pathogen can be found, yet the brain is inflamed and under attack. The umbrella term used most often in veterinary medicine is meningoencephalitis of unknown origin, or MUO. Under that umbrella sit several more specific diagnoses that can only be definitively confirmed on post-mortem examination: granulomatous meningoencephalomyelitis (GME), necrotizing meningoencephalitis (NME), and necrotizing leukoencephalitis (NLE). All three involve the immune system mounting a destructive assault on the brain and spinal cord, but the pattern and location of damage differ. In practice, because brain biopsy is rarely performed in living dogs, most of these cases are treated as MUO and managed with drugs that suppress the immune response.
Infectious Causes and How They Reach the Brain
Canine distemper virus remains one of the most devastating infectious causes of encephalitis worldwide, particularly in areas where vaccination rates are low. The virus spreads through respiratory secretions and initially attacks the respiratory and gastrointestinal tracts before crossing into the brain. Once there, it causes widespread neuronal loss and triggers a paradoxical situation: the immune system activates locally in the brain even as the virus suppresses systemic immunity elsewhere in the body.2PubMed. Acute canine distemper encephalitis is associated with rapid neuronal loss and local immune activation Dogs with neurological distemper show markedly elevated brain-damage biomarkers in their blood, including neuron-specific enolase and glial fibrillary acidic protein, reflecting how aggressively the virus destroys neural tissue.3PubMed Central. Evaluation of Selected Brain Damage Biomarkers in the Determination of Brain Damage in Dogs With Neurological Distemper Vaccination is highly effective at prevention, which is why distemper encephalitis is far more common in unvaccinated or under-vaccinated dogs.
Tick-borne encephalitis (TBE) is a growing concern in parts of Europe, caused by a flavivirus transmitted through tick bites. A retrospective study of 54 dogs diagnosed with TBE in Europe found that owners recalled recent tick exposure in only about 43% of cases, meaning the tick bite often goes unnoticed.4PubMed Central. Canine Tick-Borne Encephalitis: Clinical Features, Survival Rate and Neurological Sequelae The virus targets the central nervous system and can cause meningitis, myelitis (spinal cord inflammation), or a combination of both.5PubMed Central. Evaluation of antibodies in cerebrospinal fluid for the diagnosis of tick-borne encephalitis in dogs Cases have even been documented in the United Kingdom, where tick-borne flaviviruses were previously considered rare in dogs, raising questions about whether geographic range is expanding.6PubMed Central. Suspected tick-borne flavivirus meningoencephalomyelitis in dogs from the UK
Parasitic infections involving Neospora caninum and Toxoplasma gondii can also cause encephalitis in dogs, though these tend to be less common than viral causes. Neospora has a particular affinity for the nervous system, while Toxoplasma targets both the brain and muscle tissue.7PubMed Central. Exploring similarities and differences between Toxoplasma gondii and Neospora caninum infections in dogs In a retrospective study of dogs with encephalomyelitis, those infected with Neospora showed progressive hind limb paralysis and ataxia, with the most severe damage concentrated in the spinal cord and brainstem.8PubMed. Protozoal encephalomyelitis of dogs involving Neospora caninum and Toxoplasma gondii in New Zealand These protozoal infections are especially dangerous in immunosuppressed dogs and can be tricky to distinguish from one another without specialized testing.9Semina: Ciências Agrárias. Toxoplasma gondii, Neospora caninum, and Sarcocystis spp. in brain samples of dogs with and without neurological signs in Southern Brazil (2008-2023)
Immune-Mediated Encephalitis and the MUO Puzzle
The most common form of encephalitis diagnosed in dogs, at least in regions with good vaccination coverage, is not caused by any pathogen at all. Meningoencephalitis of unknown origin is a diagnosis of exclusion: the brain is inflamed, testing rules out infection, and the dog is treated as though the immune system is the problem. This approach works surprisingly well in many cases, which itself is evidence for an autoimmune mechanism.
GME, one of the conditions under the MUO umbrella, is marked by granulomatous lesions scattered through the brain or spinal cord, along with inflammation of the meninges and characteristic cuffing of immune cells around blood vessels.10PubMed Central. Granulomatous meningoencephalomyelitis in dogs: A review It can appear as a single mass-like lesion, mimicking a brain tumor on imaging, or as scattered inflammation throughout the nervous system. GME affects dogs of many breeds and sizes, though small breeds seem overrepresented.
NME and NLE, by contrast, are strongly tied to specific breeds. Pugs are the poster breed for NME, and a study of Yorkshire Terriers documented severe necrotizing encephalitis with a pattern that suggests a T-cell-driven immune attack.11PubMed. Severe necrotizing encephalitis in a Yorkshire terrier The location of the brain damage differs between NME and NLE in ways that tend to follow breed lines: NME primarily hits the cerebral cortex, while NLE concentrates in the white matter and thalamus.12PubMed. Comprehensive immunohistochemical studies on canine necrotizing meningoencephalitis (NME), necrotizing leukoencephalitis (NLE), and granulomatous meningoencephalomyelitis (GME)
A persistent question has been whether MUO might actually be caused by a hidden infection that current tests simply miss. Researchers have attacked this question with deep sequencing technology, analyzing cerebrospinal fluid from dogs with MUO for any trace of viral, bacterial, or parasitic genetic material. The results have been striking in their negativity: no consistent pathogen has been found. One metagenomic investigation of MUO dogs turned up scattered bacterial and viral sequences, but no single organism appeared in more than a few samples, and the results were inconsistent even between different tissue types from the same animal.13PubMed Central. Metagenomic Investigation of Idiopathic Meningoencephalomyelitis in Dogs The detected bacteria were deemed environmental contaminants. This does not completely rule out an infectious trigger, since a pathogen could theoretically set the immune response in motion and then be cleared before testing occurs, but it does strengthen the case that MUO is fundamentally an autoimmune disease.
Why Certain Breeds Are Hit Hardest
Pugs have an unusually high rate of necrotizing meningoencephalitis, and genetic research has traced much of that risk to a specific region of their DNA. A genome-wide scan identified a strong association with the dog leukocyte antigen (DLA) class II complex, a cluster of immune-system genes on chromosome 12. Affected Pugs were more likely to carry specific versions of these genes, and those gene variants were tightly linked into a single high-risk combination.14PubMed. Necrotizing meningoencephalitis of Pug dogs associates with dog leukocyte antigen class II and resembles acute variant forms of multiple sclerosis Simplified genetic testing has since been developed that can identify at-risk Pugs using just a portion of this gene region or even a small panel of genetic markers.15PubMed. Dog leukocyte antigen class II-associated genetic risk testing for immune disorders of dogs
An epidemiological study of Pugs with NME found that the typical patient was a young adult female, with a median age at symptom onset of about 18 months. Female dogs were overrepresented, and affected Pugs tended to weigh less than unaffected ones.16PubMed Central. Epidemiology of necrotizing meningoencephalitis in Pug dogs The parallels with human multiple sclerosis are hard to ignore: both conditions involve immune-system genes, both are more common in females, both have a relatively low overall incidence, and both center on inflammatory damage to the central nervous system.17PubMed. Necrotizing meningoencephalitis of Pug dogs associates with dog leukocyte antigen class II and resembles acute variant forms of multiple sclerosis The key difference is that NME in Pugs is far more aggressive, tends to hit earlier in life, and involves outright tissue death rather than the demyelination characteristic of MS.
Research into at-risk Pugs has also shown that the genetic vulnerability doesn’t guarantee disease. A study comparing Pugs who carried the high-risk gene combination to those who did not found that about 22% of the genetically at-risk group showed reproducible neurological abnormalities on serial examinations, compared to none in the low-risk group. The most common early sign was pain along multiple points of the spine, along with subtle visual and postural deficits.18Journal of Veterinary Internal Medicine. A potential early clinical phenotype of necrotizing meningoencephalitis in genetically at-risk pug dogs This suggests there may be a detectable pre-clinical phase, which could eventually open the door to earlier intervention, though this remains an active area of research.19PubMed Central. Leukocyte and cytokine variables in asymptomatic Pugs at genetic risk of necrotizing meningoencephalitis
Recognizing the Signs
Encephalitis symptoms in dogs vary depending on which part of the brain is affected, but there are common patterns. Seizures are one of the most alarming and recognizable signs, and they represent one of the strongest negative predictors of outcome. Other symptoms include a change in behavior or mental state, circling, head pressing, loss of coordination, weakness or paralysis on one or both sides of the body, visual problems, and neck pain or stiffness. Because inflammation often affects the meninges as well as the brain itself, many dogs present with signs of meningitis: a stiff neck, reluctance to move, and obvious pain when the head is manipulated.
The tricky part is that none of these signs are unique to encephalitis. Brain tumors, strokes, and certain metabolic conditions can look very similar, which is why advanced diagnostics are so important. MRI is the most useful imaging tool, and in cases of NME in Pugs, scans typically show asymmetric lesions spanning both gray and white matter, most commonly in the parietal, temporal, and occipital regions. A brain shift across the midline is common, and some dogs show herniation of brain tissue, which is a medical emergency.20PubMed. Magnetic resonance imaging characteristics of necrotizing meningoencephalitis in Pug dogs
Cerebrospinal fluid analysis adds another layer of information. In dogs with MUO, researchers have found elevated levels of specific inflammatory molecules in the spinal fluid that don’t appear in dogs with epilepsy or brain tumors. Several of these markers, including certain cytokines and chemokines, were detected exclusively in MUO cases, suggesting they could eventually serve as diagnostic tools to distinguish autoimmune brain inflammation from other neurological diseases without needing a biopsy.21PubMed Central. Cerebrospinal Fluid Cytokine and Chemokine Analysis in Dogs With Meningoencephalitis of Unknown Origin or Idiopathic Epilepsy Neuron-specific enolase, a protein released when brain cells are destroyed, has also been found at elevated levels in the spinal fluid of dogs with encephalitis, though it rises in other brain conditions too and isn’t specific enough to stand alone as a test.22Journal of Veterinary Medical Science. Proteome Analysis of Cerebrospinal Fluid in Healthy Beagles and Canine Encephalitis
Treatment Approaches
For infectious encephalitis, treatment targets the underlying pathogen. Distemper has no specific antiviral treatment, so care is mainly supportive: controlling seizures, managing secondary infections, and keeping the dog comfortable while the immune system fights the virus. The prognosis for neurological distemper is guarded at best. Parasitic causes like Neospora and Toxoplasma can be treated with antiprotozoal drugs, though recovery depends heavily on how much damage the brain has sustained before treatment begins.
For immune-mediated encephalitis and MUO, the standard approach involves suppressing the immune system. Corticosteroids, usually prednisone, are the foundation. They reduce inflammation quickly and are often the first drug started. But steroids alone are rarely enough for long-term control, so they’re typically paired with a second immunosuppressive agent. Cytosine arabinoside, a chemotherapy drug that also suppresses the immune system, is one of the most studied options. In a series of ten dogs with MUO treated with prednisone and cytosine arabinoside, all achieved partial or complete remission, and the median survival time was 531 days, with half the dogs still alive at the time the study was published.23PubMed. Combined cytosine arabinoside and prednisone therapy for meningoencephalitis of unknown aetiology in 10 dogs
Mycophenolate mofetil is another immunosuppressive drug that has gained traction. A study of 25 dogs with MUO treated with mycophenolate and corticosteroids reported a median survival of 731 days, with 92% of dogs showing neurological improvement within the first month.24PubMed Central. Treatment of canine meningoencephalomyelitis of unknown aetiology with mycophenolate mofetil and corticosteroids Perhaps even more interesting, a Chihuahua with presumed MUO achieved complete MRI-confirmed remission on a steroid-free protocol using leflunomide and mycophenolate together, which appears to be the first documented case of full remission without any steroid use.25PubMed Central. Complete MRI-confirmed remission of presumptive meningoencephalitis of unknown origin in a Chihuahua using a steroid-free combination of leflunomide and mycophenolate mofetil This matters because long-term steroid use carries its own significant side effects in dogs, including weight gain, muscle wasting, increased thirst and urination, and susceptibility to infections. Steroid-sparing protocols could improve quality of life substantially if they prove broadly effective.
What Determines Whether a Dog Recovers
Prognosis in MUO varies widely. Some dogs respond well to treatment and live for years with minimal disability. Others deteriorate rapidly despite aggressive therapy. Research has identified several factors that predict worse outcomes. Pugs as a breed carry a higher risk of not surviving to six months after diagnosis. Seizures at presentation, limb weakness or paralysis, and a higher overall disability score are all associated with poorer survival.26PubMed Central. Prognosis in meningoencephalitis of unknown origin in dogs Dogs whose symptoms don’t fully resolve within the first six months are more likely to relapse.
Imaging findings matter too. Loss of the normal brain surface folds and herniation of brain tissue through the base of the skull on MRI are both associated with increased risk of death. A key practical finding is that stopping immunosuppressive treatment before MRI lesions have fully resolved leads to relapse, essentially every time.27PubMed. Meningoencephalitis of unknown origin: investigation of prognostic factors and outcome using a standard treatment protocol This makes follow-up imaging an important part of management, not just an optional extra. Combining MRI with repeat cerebrospinal fluid analysis gives the best sensitivity for predicting which dogs will relapse, better than either test alone.
Parallels With Human Autoimmune Encephalitis
One of the more compelling threads in recent veterinary neurology research is the growing evidence that some dogs with MUO produce the same type of antibodies found in humans with autoimmune encephalitis. In people, antibodies that attack specific brain proteins, particularly the NMDA receptor, cause a well-characterized syndrome of seizures, psychiatric symptoms, and movement disorders. Researchers tested cerebrospinal fluid from dogs with neurological disease and found anti-NMDA receptor antibodies in a subset of them. All three dogs with these antibodies responded to standard MUO treatment.28PubMed Central. Presence of cerebrospinal fluid antibodies associated with autoimmune encephalitis of humans in dogs with neurologic disease
A more recent study expanded on this finding, successfully detecting neural autoantibodies in a subset of dogs with non-infectious inflammatory brain disease. The researchers argued that dogs with these antibodies should be compared directly to the equivalent human conditions, and that identifying these antibodies could eventually guide treatment decisions and help predict outcomes.29Journal of Veterinary Internal Medicine. Detection of neural autoantibodies in dogs with non-infectious inflammatory central nervous system disorders In human medicine, autoimmune encephalitis caused by specific antibodies often responds to targeted treatments like plasma exchange or rituximab. If the same antibody-driven mechanism operates in at least some dogs with MUO, it could eventually lead to more precise, less blunderbuss approaches to treatment than the current strategy of broad immunosuppression.
The connection runs both ways. Dogs with NME have already been recognized as a naturally occurring model for studying aggressive autoimmune brain diseases in humans, given the DLA class II genetic association that mirrors the human leukocyte antigen associations in multiple sclerosis.30PubMed. Necrotizing meningoencephalitis of Pug dogs associates with dog leukocyte antigen class II and resembles acute variant forms of multiple sclerosis Understanding what goes wrong in the canine immune system could shed light on what drives similar diseases in people, and vice versa. It’s a rare case where pet dogs and their owners could both benefit from the same line of research.
Tick-Borne Encephalitis as an Emerging Concern
While immune-mediated encephalitis dominates the caseload in well-vaccinated dog populations, tick-borne encephalitis deserves special mention because its geographic range appears to be shifting. TBE virus is endemic across much of central and northern Europe, and dogs in these regions are regularly exposed through tick bites during warmer months. The retrospective study of 54 European dogs diagnosed with TBE found that all cases occurred between March and October, consistent with tick activity seasons.31PubMed Central. Canine Tick-Borne Encephalitis: Clinical Features, Survival Rate and Neurological Sequelae Clinical presentations varied: a small fraction of dogs showed only meningitis, while the majority had some combination of brain and spinal cord involvement.
The emergence of tick-borne flavivirus cases in UK dogs in 2021 was considered noteworthy enough to warrant a published case series, since TBE had not historically been recognized as a dog disease in Britain.32PubMed Central. Suspected tick-borne flavivirus meningoencephalomyelitis in dogs from the UK Whether this represents a genuine expansion of the virus’s range, a previously unrecognized presence of louping ill virus affecting dogs, or simply better diagnostic awareness remains unclear. For dog owners in tick-endemic areas, the practical takeaway is straightforward: consistent tick prevention is one of the few ways to reduce the risk of a form of encephalitis that has no specific treatment once it takes hold. Unlike distemper, there is no canine vaccine for TBE, so prevention relies entirely on keeping ticks off the dog.